ABSTRACT Cells from patients with ataxia telangiectasia, a rare autosomal recessive disease characterized by primary neuronal degeneration, are abnormally sensitive to the DNA-damaging chemical N-methyl-N'-nitro-N-nitrosoguanidine. We have conducted experiments to determine whether more common primary neuronal degenerations also have a hypersensitivity to this radiomimetic chemical. Fibroblast strains from 13 control donors and from 13 patients with inherited primary neuronal degenerations were treated in vitro with the chemical, and the strains' sensitivity to the chemical was then determined by measuring their ability to divide and form colonies. Twelve ofthe 13 patient strains, including the 6 Huntington disease and the 4 familial dysautonomia strains, were abnormally sensitive. This hypersensitivity, which is believed to reflect defective repair of the chemically-induced DNA damage, might provide the basis for presymptomatic and prenatal diagnostic tests for these disorders and for elucidating their pathogenesis.
Primary neuronal degenerations are progressive diseases characterized by premature death ofneurons in the absence ofpathological evidence ofa specific cause (1) . Metabolic abnormalities have been adequately identified and confirmed in cultured cells from only two rare forms of these diseases, the autosomal recessive disorders xeroderma pigmentosum (XP) (2, 3) and ataxia telangiectasia (AT) (3) (4) (5) . Patients with XP have hereditary defects in mechanisms that repair DNA damaged by UV radiation and by UV-mimetic chemicals; as a result, their cells are hypersensitive to the lethal effects ofsuch agents (3, 6) . Cells from patients with AT are hypersensitive to the lethal effects of ionizing radiation and ofradiomimetic chemicals such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (3) (4) (5) . Based on these findings, it has been suggested that defective repair ofneuronal DNA damaged in vivo by endogenous chemicals is responsible for the premature death of neurons which results in these patients' neurological abnormalities (2, (6) (7) (8) (9) . It also has been suggested that other neurodegenerative disease (7) (8) (9) , and particularly other primary neuronal degenerations (9) , may be caused by defective repair of neuronal DNA. These postulates already have received support from recent brief reports that cells from patients with Huntington disease (HD) (9-11, ¶), Friedreich ataxia (12) , familial dysautonomia (FD) (13) , and olivopontocerebellar atrophy (13) are abnormally sensitive to ionizing radiation. We now report in detail on our findings that these disorders have an even greater hypersensitivity to the lethal effects of MNNG. Preliminary results have been published (14, 15) .
MATERIALS AND METHODS
Fibroblast Strains. Strains with 'CRL' and 'GM' prefixes were obtained, respectively, from the American Type Culture Collection (Rockville, MD) and The Human Genetic Mutant Cell Repository (Camden, NJ). All patient strains were obtained from the Camden Repository, and clinical data and other pertinent information concerning these strains is reported in the Repository's catalogue (16) . Strain (17) : "Friedreich ataxia" with optic atrophy and sensorineural deafness (19) . We shall refer to strain GM 3295 as a "Friedreich variant."
Culturing ofFibroblasts. Fibroblasts were cultured, treated, and tested by the method ofScudiero (5) . Fibroblast stocks were grown in Dulbecco's modification of Eagle's minimal essential medium containing 0.01 mg of gentamicin, 60 units of penicillin, and 0.06 mg of streptomycin per ml; 2% (vol/vol) minimal essential medium nonessential amino acids 100 times concentrated; and 10% (vol/vol) fetal bovine serum (GIBCO). Cells were passaged once a week at split ratios of 1:3 and cultured at 370C in 10% CQ/90% air with >95% humidity. One day prior to MNNG or UV treatment, stationary-phase cultures were taken up in trypsin/EDTA, centrifuged, and resuspended in complete Ham's F12 medium (GIBCO), which contained 20% fetal bovine serum and 0.01 mg ofgentamicin, 60 units of penicillin, and 0.06 mg of streptomycin per ml. The cells were counted and plated into 60-mm Petri dishes (Corning).
Colony-Forming Ability After MNNG Addition. On the following day, stock solutions of MNNG (Aldrich) in ethanol were diluted into fresh, prewarmed complete Ham's F12 medium, which was then added to the Petri dishes from which the overnight growth medium hadjust been removed. After one hr with MNNG at 370C in an atmosphere of5% C02/95% air, the cells were washed once with fresh, complete Ham's F12 medium and The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 CFA After UV Exposure. On the day after the cells were plated into the Petri dishes, the logarithmically growing fibroblasts were washed with phosphate-buffered saline and irradiated in their Petri dishes with a germicidal lam? (General Electric lamp no. G15T8) at a dose rate of 1.56 W m-. The cells were then incubated, fed, and evaluated as described for the MNNG-treated fibroblasts.
CFA Parameters and Statistical Analysis After MNNG Treatment. The CFA curve for each strain after MNNG treatment was obtained by plotting the log of the percentage of remaining CFA after treatment as a function of the MNNG dosage. Although the CFA curves had variable shapes at low doses, each curve had a long exponential portion at high doses, which began at the 4MtM dose in series I and at the 6 ,uM dose in series II and III. In each experiment with a strain, a straight line was fit to the logarithms ofthe CFA values at the high doses by using the method ofleast squares. From each straight line, three CFA parameters were obtained by computer: the Do, Do,, and D10 values. The Do value is the concentration of MNNG that reduces the CFA from any point on the exponential portion of the curve to 37% of that point. The Do, and the D10 values are the concentrations of MNNG that reduce the CFA to 1% and 10%, respectively, of the colony-forming efficiency of the untreated cells. For each ofthese CFA parameters (DO, Do,, and D10), the value reported for each strain in a series is computed from the line obtained by averaging the slopes and intercepts from the two to seven experiments performed on that strain. Comparisons of CFA parameters among cell strains or between groups of cell strains were made by analysis of variance methods (20) , and two-sided P values are reported.
RESULTS
The overall ranges of colony-forming efficiencies of untreated strains from all of our experiments were as follows: control donor, 1-32%; HD, 1-39%; FD, 3-35%; infantile spinal muscular atrophy, 3-11%; spinocerebellar ataxia, 2-15%; Friedreich variant, 2-10%. Thus, the untreated-patient strains had colonyforming efficiencies that were comparable with those of the control donor strains. Differences in colony-forming efficiency of untreated cells had no discernible effect on the CFA after MNNG treatment of control donor (Fig. 1A) , HD (Fig. 1B) , or FD (Fig. 1C) strains. Therefore, any differences in CFA between patient and control donor strains after MNNG treatment were not due to differences between the colony-forming efficiencies of the untreated strains. Fig. 2A shows (Fig. 2A) curve after UV treatment of strain CRL 1223 from XP patient XP12BE, whose cells show the defective repair ofUV-damaged DNA characteristic of this disease (2, 6) . Fig. 3 A-C shows the CFA curves after MNNG treatment ofthe strains studied in series II. The curves for the seven control donor strains (open symbols) were obtained concurrently with the curves for the six unrelated HD strains (Fig. 3A) , the four FD strains representing three kindreds (GM 2341 and GM 2342 are brothers) (Fig. 3B) , and the Freidreich variant, infantile spinal muscular atrophy, and spinocerebellar ataxia strains (Fig. 3C) . Six ofthe control donor strains studied in series I were also studied in series II. Five ofthese six strains had significantly higher Do (P < 0.05), Do, (P < 0.01), and D10 (P < 0.05) values in series II than in series I. In contrast to the variation among the control donor strains in series I, in series II there was no significant variation among the control donor strains' Do (P = 0.33), Do, (P = 0.26), or D1o (P = 0.07) values.
All six of the HD strains in series II showed hypersensitivity to MNNG (closed symbols, Fig. 3A) The four FD strains ( Fig. 3B ; Table 1 ) were also hypersensitive to MNNG. Each of the four FD strains had significantly lower Do, Do,, and D10 values (P < 0.05) than each ofthe seven control donor strains had with the exception of FD strain GM 2342, whose D10 value was not significantly different from the D10 values of control donor strains CRL 1220 (P = 0.15) and CRL 1295 (P = 0.08). Although FD strain GM 850 had a significantly steeper slope and smaller Do, and DIo values than the other FD strains had (P < 0.01), the FD siblings' strains had CFA curves after MNNG treatment that were practically identical with each other (Fig. 3B; Table 1 ).
In series II (Fig. 3C ) and in series I ( Fig. 2A) , the infantile spinal muscular atrophy and spiocerebellar ataxia strains were hypersensitive to MNNG, whereas the Friedreich variant strain was not. With the exception of the Do value for the infantile spinal muscular atrophy strain, the Do, Do,, and D1o values for these two sensitive strains were significantly less (P < 0.01) than the corresponding values for each of the control donor strains (Table 1 ). The infantile spinal muscular atrophy strain's Do value was not significantly below the Do value of control strain CRL 1652 (P = 0.06). The Friedreich variant strain had Do, Do,, and D1o values ( Table 1) that were significantly higher (P < 0.05) than the corresponding parameters for all control donor strains except strain CRL 1187 (P = 0.33). Fig. 3D shows the results of the coded strains studied in series III; the five control donor strains had not been studied in series I or II. Three of these five coded control donor strains were chosen because they had been reported to us to have the lowest CFA after MNNG treatment ofnine control donor strains in a preliminary study by others that used the MNNG survival test of Jacobs and DeMars (21) . Ihe other two coded control donor strains were chosen because one reportedly had intermediate CFA and the other had high CFA after MNNG treatment among the nine control donor strains in that test. These In series III the two HD strains were again found-to be hypersensitive to MNNG (Fig. 3D) We have reported that lymphocyte lines from four HD patients (9), two FD patients (13) , and one tuberous sclerosis patient (22) were hypersensitive to x-rays as shown by the number of viable (i.e., trypan blue-excluding) lymphocytes present in' the cultures on the third day after irradiation. We subsequently found (unpublished data) a similar hypersensitivity to x-rays in lymphocyte lines from all of the following additional unrelated patients studied: three with HD, three with FD, and one with tuberous sclerosis. These studies were conducted under conditions in which the lymphocyte viability assay had a sensitivity and discrimination enabling it to distinguish from normal all five AT homozygote lines (9) and all five of the even less sensitive AT heterozygote lines (9) . Since these lymphocyte studies were completed, our lymphocyte viability assay, which had been used by Chen et aL (23) to distinguish the viability after x-ray treatment ofeight AT heterozygote and six AThomozygote lines from that of normal lines, has currently lost its ability to distinguish from normal any line except the AT homozygote lines, and even these lines now show survival (after x-ray treatment) in the range previously exhibited by the AT heterozygote lines. Nevertheless, in this lymphocyte viability assay when successfully used by us (9) and by Chen et aL (23) , a total of 13 AT heterozygote lines have been tested, and all 13 were found to have viability after x-ray treatment which was intermediate between that of the AT homozygote and the normal lines and similar in degree to that which we found for our other sensitive lymphocyte lines (i.e., the seven HD, five FD, and two tuberous sclerosis lymphocyte lines). Combining the results of our lymphocyte/x-ray and fibroblast/MNNG survival tests, we have found hypersensitivity to induced DNA damage in all 11 HD and eight FD kindreds tested. Hypersensitivity to ionizing radiation has been found also in post-irradiation CFA experiments with fibroblast strains from AT heterozygotes (4, 24, 25, ¶) and from HD (10, 11, ¶) and tuberous sclerosisT patients.
It is important to note that although the fibroblast-MNNG test is not specific for any disease, it might prove useful in We are grateful to Ms. Rosemary Cuddy for critical comments on the manuscript.
